237 related articles for article (PubMed ID: 28066250)
21. The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer.
Howell SJ; Johnston SR; Howell A
Best Pract Res Clin Endocrinol Metab; 2004 Mar; 18(1):47-66. PubMed ID: 14687597
[TBL] [Abstract][Full Text] [Related]
22. Selective estrogen modulators as an anticancer tool: mechanisms of efficiency and resistance.
Sengupta S; Jordan VC
Adv Exp Med Biol; 2008; 630():206-19. PubMed ID: 18637493
[TBL] [Abstract][Full Text] [Related]
23. Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland.
Peano BJ; Crabtree JS; Komm BS; Winneker RC; Harris HA
Endocrinology; 2009 Apr; 150(4):1897-903. PubMed ID: 19022889
[TBL] [Abstract][Full Text] [Related]
24. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
Lewis JS; Jordan VC
Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
[TBL] [Abstract][Full Text] [Related]
25. Selective estrogen receptor modulators: mechanism of action and clinical experience. Focus on raloxifene.
Thiebaud D; Secrest RJ
Reprod Fertil Dev; 2001; 13(4):331-6. PubMed ID: 11800172
[TBL] [Abstract][Full Text] [Related]
26. Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists.
Pandey P; Roy KK; Liu H; Ma G; Pettaway S; Alsharif WF; Gadepalli RS; Rimoldi JM; McCurdy CR; Cutler SJ; Doerksen RJ
Molecules; 2018 Oct; 23(10):. PubMed ID: 30322136
[TBL] [Abstract][Full Text] [Related]
27. [Effect of selective estrogen receptor modulators on estrogen-sensitive tissues].
Jirecek S; Pavo I; Huber JC
Gynakol Geburtshilfliche Rundsch; 1999; 39(4):184-90. PubMed ID: 10629380
[TBL] [Abstract][Full Text] [Related]
28. Behavioral effects of cannabinoid agents in animals.
Chaperon F; Thiébot MH
Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological actions of cannabinoids.
Pertwee RG
Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
[TBL] [Abstract][Full Text] [Related]
30. Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development.
Gennari L; Merlotti D; Valleggi F; Martini G; Nuti R
Drugs Aging; 2007; 24(5):361-79. PubMed ID: 17503894
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of (3',5'-dichloro-2,6-dihydroxy-biphenyl-4-yl)-aryl/alkyl-methanone selective CB2 inverse agonist.
Presley CS; Mustafa SM; Abidi AH; Moore BM
Bioorg Med Chem; 2015 Sep; 23(17):5390-401. PubMed ID: 26275680
[TBL] [Abstract][Full Text] [Related]
32. Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets.
Mallipeddi S; Janero DR; Zvonok N; Makriyannis A
Biochem Pharmacol; 2017 Mar; 128():1-11. PubMed ID: 27890725
[TBL] [Abstract][Full Text] [Related]
33. Endometrial safety: a key hurdle for selective estrogen receptor modulators in development.
Pinkerton JV; Goldstein SR
Menopause; 2010; 17(3):642-53. PubMed ID: 20107426
[TBL] [Abstract][Full Text] [Related]
34. An overview of current and emerging SERMs.
Komm BS; Mirkin S
J Steroid Biochem Mol Biol; 2014 Sep; 143():207-22. PubMed ID: 24667357
[TBL] [Abstract][Full Text] [Related]
35. Selective estrogen receptor modulation: the search for an ideal hormonal therapy for breast cancer.
Dhingra K
Cancer Invest; 2001; 19(6):649-59. PubMed ID: 11486708
[TBL] [Abstract][Full Text] [Related]
36. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
[TBL] [Abstract][Full Text] [Related]
37. Selective Estrogen Receptor Modulators.
An KC
Asian Spine J; 2016 Aug; 10(4):787-91. PubMed ID: 27559463
[TBL] [Abstract][Full Text] [Related]
38. Cannabidiol skews biased agonism at cannabinoid CB
Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
[TBL] [Abstract][Full Text] [Related]
39. Unique SERM-like properties of the novel fluorescent tamoxifen derivative FLTX1.
Marrero-Alonso J; Morales A; García Marrero B; Boto A; Marín R; Cury D; Gómez T; Fernández-Pérez L; Lahoz F; Díaz M
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):898-910. PubMed ID: 23727370
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment.
Dobovišek L; Krstanović F; Borštnar S; Debeljak N
Cancers (Basel); 2020 Feb; 12(3):. PubMed ID: 32106399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]